These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 35554591)
41. Deprescribing: Polypharmacy management in older adults with comorbidities. Diggins K Nurse Pract; 2019 Jul; 44(7):50-55. PubMed ID: 30950910 [TBL] [Abstract][Full Text] [Related]
42. Effects of continuous positive airway pressure on blood pressure and daytime sleepiness in obstructive sleep apnea patients with coronary heart diseases under optimal medications. Zhao Q; Liu ZH; Luo Q; Zhao ZH; Zhang HL; Wang Y Sleep Breath; 2012 Jun; 16(2):341-7. PubMed ID: 21337116 [TBL] [Abstract][Full Text] [Related]
43. Views of medical practitioners about deprescribing in older adults: Findings from an Italian qualitative study. D'Avanzo B; Agosti P; Reeve E; Pasina L; Sabbà C; Mannucci PM; Nobili A Maturitas; 2020 Apr; 134():29-33. PubMed ID: 32143773 [TBL] [Abstract][Full Text] [Related]
44. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland. Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397 [TBL] [Abstract][Full Text] [Related]
45. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial. Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ; JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368 [TBL] [Abstract][Full Text] [Related]
46. Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria. Curtin D; Jennings E; Daunt R; Curtin S; Randles M; Gallagher P; O'Mahony D J Am Geriatr Soc; 2020 Apr; 68(4):762-769. PubMed ID: 31868920 [TBL] [Abstract][Full Text] [Related]
47. Deprescribing in nursing homes: Protocol for nested, randomised controlled hybrid trials of deprescribing interventions. Cateau D; Ballabeni P; Mena S; Bugnon O; Niquille A Res Social Adm Pharm; 2021 Apr; 17(4):786-794. PubMed ID: 32622774 [TBL] [Abstract][Full Text] [Related]
48. Drug Therapy in Obstructive Sleep Apnea. Hedner J; Zou D Sleep Med Clin; 2018 Jun; 13(2):203-217. PubMed ID: 29759271 [TBL] [Abstract][Full Text] [Related]
49. Association between deprescribing from polypharmacy and functional recovery and home discharge among older patients with sarcopenia after stroke. Kose E; Matsumoto A; Yoshimura Y Nutrition; 2023 Jul; 111():112040. PubMed ID: 37141661 [TBL] [Abstract][Full Text] [Related]
50. [Obstructive sleep apnea syndrome and cardiovascular risk factors in the antihypertensive therapy "escape" phenomenon]. Mikhailova OO; Elfimova EM; Litvin AY; Chazova IE Ter Arkh; 2023 Feb; 95(1):17-22. PubMed ID: 37167111 [TBL] [Abstract][Full Text] [Related]
51. Deprescribing perceptions and practice reported by multidisciplinary hospital clinicians after, and by medical students before and after, viewing an e-learning module. Ng B; Duong M; Lo S; Le Couteur D; Hilmer S Res Social Adm Pharm; 2021 Nov; 17(11):1997-2005. PubMed ID: 33773940 [TBL] [Abstract][Full Text] [Related]
52. Untreated Obstructive Sleep Apnea Is Associated With Myocardial Injury Independent of Blood Pressure Control in Hypertension. Lui MMS; Tse HF; Mak JCW; Lam DCL; Chan CWS; Chong PWC; Ip MSM J Clin Sleep Med; 2018 Nov; 14(11):1841-1847. PubMed ID: 30373683 [TBL] [Abstract][Full Text] [Related]
54. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Ailabouni N; Mangin D; Nishtala PS Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492 [TBL] [Abstract][Full Text] [Related]
55. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study. Komagamine J; Sugawara K; Hagane K BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778 [TBL] [Abstract][Full Text] [Related]
56. Influence of high risk of obstructive sleep apnea on adherence to antihypertensive treatment in outpatients. Righi CG; Martinez D; Gonçalves SC; Gus M; Moreira LB; Fuchs SC; Fuchs FD J Clin Hypertens (Greenwich); 2017 May; 19(5):534-539. PubMed ID: 28266781 [TBL] [Abstract][Full Text] [Related]
57. LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care. Reus X; Sastre ML; Leiva A; Sánchez B; García-Serra C; Ioakeim-Skoufa I; Vicens C Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293832 [TBL] [Abstract][Full Text] [Related]
58. The value of deprescribing in older adults with dementia: a narrative review. Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630 [No Abstract] [Full Text] [Related]
59. Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine. Svedmyr S; Hedner J; Bonsignore MR; Lombardi C; Parati G; Ludka O; Zou D; Grote L; J Sleep Res; 2023 Aug; 32(4):e13811. PubMed ID: 36539972 [TBL] [Abstract][Full Text] [Related]
60. Obstructive sleep apnea treatment in adults. Chang HP; Chen YF; Du JK Kaohsiung J Med Sci; 2020 Jan; 36(1):7-12. PubMed ID: 31512369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]